Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effect of oral testosterone treatment on serum concentrations of sex steroids gonadotrophins and prolactin in alcoholic cirrhotic men. Copenhagen Study Group for Liver Diseases

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Editorial: suicide and IBD-a call to action. Authors' reply

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Exercise-Based Rehabilitation for Heart Failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis

    Research output: Contribution to journalReviewResearchpeer-review

  3. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B

    Research output: Contribution to journalReviewResearchpeer-review

  4. Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years

    Research output: Contribution to journalReviewResearchpeer-review

  5. Power estimations for non-primary outcomes in randomised clinical trials

    Research output: Contribution to journalJournal articleResearchpeer-review

  • C Gluud
  • Patrick Bennett
  • Bo Svenstrup
  • S Micic
View graph of relations
The aim of this study was to examine the serum concentrations of sex steroids and pituitary hormones in a randomly selected group of alcoholic cirrhotic men participating in a randomized, placebo-controlled study on the efficacy of oral testosterone treatment on the liver. Before treatment, patients (n = 25) had median serum concentrations of testosterone, oestradiol, non-protein bound oestradiol, non-sex hormone binding globulin (SHBG) bound oestradiol and oestrone sulphate which did not differ significantly from those of healthy controls (n = 16), but the patients had significantly (P less than 0.01) higher median serum concentrations of oestrone, luteinizing hormone (LH), follicle-stimulating hormone (FSH) and prolactin. The patients were randomized to treatment with either oral micronized testosterone (200 mg t.d.s.) or placebo for a median duration of 1 year. In the placebo group (n = 8), hormone concentrations at follow-up were not significantly different from those at entry apart from a significant (P less than 0.05) increase in FSH concentrations. Median concentrations of testosterone, oestrone, and oestrone sulphate increased significantly (P less than 0.05) in the testosterone-treated group (n = 17) when compared with concentrations at entry and concentrations in the placebo group. The testosterone-treated group had significantly (P less than 0.05) higher serum concentrations of non-protein bound and non-SHBG bound oestradiol when compared with concentrations at entry, but no significant changes were observed regarding serum oestradiol and prolactin concentrations. Both LH and FSH concentrations decreased significantly (P less than 0.05) in the testosterone-treated group when compared with concentrations at entry and concentrations in the placebo group.
Original languageEnglish
JournalAlimentary Pharmacology and Therapeutics
Volume2
Issue number2
Pages (from-to)119-28
Number of pages10
ISSN0269-2813
Publication statusPublished - Apr 1988

    Research areas

  • Adult, Double-Blind Method, Female, Gonadal Steroid Hormones, Gonadotropins, Humans, Liver Cirrhosis, Alcoholic, Middle Aged, Prolactin, Testosterone

ID: 38930537